Back to News
Market Impact: 0.15
Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®
Source: PR Newswire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Meant Health announced an expansion of its digital-health telehealth platform to provide access to FDA-approved GLP-1 medications, connecting patients with licensed clinicians for evaluation, prescriptions and ongoing care coaching. The expansion broadens the company’s obesity and metabolic-care offering, but the release provides no financial targets, patient volumes, pricing, or expected revenue impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- SpaceX weighting in Nasdaq 100 set to more than double
- Stocks stumble on inflation fears, but 2 of our names give us reasons to stay bullish
- Dell Booked More AI Server Orders in 3 Months Than It Recorded in Total Revenue
- Hyundai Motor to roll out in-house driver-assist system in 2029
- OpenAI IPO will not happen in 2026 amid AI safety fears, Sam Altman says
- The ghost cartel — your pricing algorithm may have stopped competing without your knowledge